hair relaxer litigation status

Disclaimer: This article is informational only and does not constitute legal advice. Mass tort and class action eligibility, deadlines, and settlement procedures vary by jurisdiction and individual circumstances. For specific case evaluation, consult a qualified attorney licensed in your state. Any payout ranges mentioned reflect publicly disclosed settlement administrator data and do not guarantee individual outcomes. As of early 2026, the hair relaxer multi-district litigation (MDL 3060) has transitioned from its foundational procedural phase into a high-stakes period of intensive discovery and trial preparation. Thousands of women across the United States have filed lawsuits against major cosmetic manufacturers, alleging that long-term exposure to endocrine-disrupting chemicals (EDCs) in chemical hair straightening products led to the development of uterine cancer, endometrial cancer, and ovarian cancer. For many plaintiffs, 2026 represents a “make or break” year, as the first bellwether trials are prepared for presentation before a jury in the Northern District of Illinois. The litigation, presided over by Judge Mary Rowland, continues to expand in scope as new scientific data emerges and additional plaintiffs join the consolidated proceedings. According to U.S. District Courts (USDC) — JPML Multi-District Litigation data, the hair relaxer MDL remains one of the fastest-growing mass torts in the federal system. For consumers navigating this complex legal landscape, understanding the current procedural status and the significance of upcoming court deadlines is essential for tracking the potential for future global settlements or individual trial verdicts. Current Procedural Status of MDL 3060 in 2026 The hair relaxer litigation is currently centered in the Northern District of Illinois, where Judge Mary Rowland oversees the coordinated pretrial proceedings. As of January 2026, the court has processed thousands of Short Form Complaints, which allow individual plaintiffs to join the MDL by adopting the allegations set forth in the Master Administrative Complaint. This streamlined process is a hallmark of multi-district litigation, designed to conserve judicial resources while allowing for individualized discovery regarding specific injuries and product usage history. One of the primary focuses in 2026 is the completion of “core discovery,” which involves the exchange of internal documents from defendant corporations and the deposition of key corporate executives and scientific experts. The Plaintiff Steering Committee (PSC) is currently analyzing millions of pages of internal communications to determine what the manufacturers knew about the risks of phthalates and other EDCs—and when they knew it. This phase is critical because it establishes the evidentiary basis for the …